AbCellera (ABCL)
9.34
+2.41 (34.78%)
Upcoming Events
Latest Headlines
The Catalysts are Back: Socket Mobile Breaks Out while Biotechs Race Toward Major Milestones
August 10, 2026 10:40 AM - StreetInsider
AI Found an Influenza Target That Survives Viral Mutation
August 10, 2026 9:10 AM - StreetInsider
Form 8-K AbCellera Biologics Inc. For: Aug 10
August 10, 2026 7:49 AM - SEC Filing
AbCellera Phase 2 trial shows ABCL635 cuts hot flash frequency by 83%
August 10, 2026 7:00 AM - StreetInsider
AbCellera Announces Positive Top-Line Phase 2 Clinical Trial Results for ABCL635, Demonstrating Significant Reduction in Frequency and Severity of Vasomotor Symptoms and a Favorable Tolerability Profi
August 10, 2026 7:00 AM - BizWire
Form 8-K AbCellera Biologics Inc. For: Aug 07
August 7, 2026 4:44 PM - SEC Filing
AbCellera to release phase 2 trial data for menopause drug Aug. 10
August 7, 2026 4:30 PM - StreetInsider
AbCellera to Announce Top-Line Results from the Phase 2 Trial of ABCL635 for the Treatment of Moderate-to-Severe VMS Due to Menopause on Monday, August 10, 2026
August 7, 2026 4:30 PM - BizWire
AbCellera Biologics (ABCL) PT Raised to $9 at Stifel
August 6, 2026 8:09 AM - StreetInsider
Form 10-Q AbCellera Biologics Inc. For: Jun 30
August 5, 2026 4:30 PM - SEC Filing
Form 8-K AbCellera Biologics Inc. For: Aug 05
August 5, 2026 4:23 PM - SEC Filing
AbCellera (ABCL) Misses Q2 EPS by 1c
August 5, 2026 4:06 PM - StreetInsider
AbCellera Reports Q2 2026 Business Results
August 5, 2026 4:05 PM - BizWire
Form 8-K AbCellera Biologics Inc. For: Jul 29
July 29, 2026 11:39 AM - SEC Filing
AbCellera and Vertex team up on T-cell engager drugs for autoimmune
July 29, 2026 7:00 AM - StreetInsider
AbCellera Announces Collaboration with Vertex to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other Conditions
July 29, 2026 7:00 AM - BizWire
Cantor Fitzgerald Reiterates Overweight Rating on AbCellera Biologics (ABCL)
July 17, 2026 9:55 AM - StreetInsider
AbCellera to Report Second Quarter 2026 Financial Results on August 5, 2026
July 7, 2026 4:05 PM - BizWire
Benchmark Upgrades AbCellera Biologics (ABCL) to Buy
July 7, 2026 6:16 AM - StreetInsider
Form 4 AbCellera Biologics Inc. For: Jul 01 Filed by: Seely Lynn
July 6, 2026 6:21 PM - SEC Filing
Form 3 AbCellera Biologics Inc. For: Jun 30 Filed by: Seely Lynn
July 6, 2026 6:15 PM - SEC Filing
Form 4 AbCellera Biologics Inc. For: Jul 01 Filed by: Sandor Victor
July 6, 2026 6:05 PM - SEC Filing
Form 8-K AbCellera Biologics Inc. For: Jun 30
July 6, 2026 2:54 PM - SEC Filing
AbCellera adds Lynn Seely to its board of directors
July 6, 2026 9:00 AM - StreetInsider
AbCellera Appoints Dr. Lynn Seely to its Board of Directors
July 6, 2026 9:00 AM - BizWire
Form 8-K AbCellera Biologics Inc. For: Jun 17
June 17, 2026 12:38 PM - SEC Filing
Jazz Pharmaceuticals and AbCellera ink antibody research deal
June 17, 2026 7:01 AM - StreetInsider
Jazz Pharmaceuticals and AbCellera Announce Collaboration to Discover Next-Generation T-cell Engaging Multispecific Antibodies
June 17, 2026 7:00 AM - BizWire
Form 4 AbCellera Biologics Inc. For: Jun 11 Filed by: Hayden Michael R
June 12, 2026 1:04 PM - SEC Filing
Form 4 AbCellera Biologics Inc. For: Jun 11 Filed by: Quake Stephen
June 12, 2026 1:03 PM - SEC Filing
Form 4 AbCellera Biologics Inc. For: Jun 11 Filed by: Montalbano John S.
June 12, 2026 1:02 PM - SEC Filing
Form 8-K AbCellera Biologics Inc. For: Jun 11
June 12, 2026 12:12 PM - SEC Filing
Form 3 AbCellera Biologics Inc. For: Jun 01 Filed by: Sandor Victor
June 11, 2026 1:50 PM - SEC Filing
Form 8-K AbCellera Biologics Inc. For: Jun 01
June 5, 2026 12:04 PM - SEC Filing
AbCellera appoints Dr. Victor Sandor to board of directors
June 5, 2026 9:00 AM - StreetInsider
AbCellera Appoints Dr. Victor Sandor to its Board of Directors
June 5, 2026 9:00 AM - BizWire
Form 4 AbCellera Biologics Inc. For: Jun 03 Filed by: Booth Andrew
June 3, 2026 2:23 PM - SEC Filing
AbCellera Biologics (ABCL) PT Raised to $12 at Truist Securities
May 22, 2026 7:05 AM - StreetInsider
Increasing unusual put option volume: TIGR XLI EXE INFQ ABCL FUTU INTU CMPS ADMA
May 21, 2026 9:57 AM - StreetInsider
Form 4 AbCellera Biologics Inc. For: May 14 Filed by: Montalbano John S.
May 18, 2026 12:10 PM - SEC Filing
AbCellera Biologics (ABCL) PT Raised to $11 at Cantor Fitzgerald Post Q1 Print, Trial Data
May 12, 2026 8:50 AM - StreetInsider
AbCellera Biologics (ABCL) PT Raised to $8 at Stifel on Positive Data for ABCL635
May 12, 2026 7:27 AM - StreetInsider
AbCellera Biologics (ABCL) PT Raised to $13 at Jones Trading
May 12, 2026 7:09 AM - StreetInsider
Full Article List
